The authors are saddened to report the passing in March 2011 of Thomas Littlejohn, III, MD, esteemed physician, investigator, colleague, and co-author of posters and publications from the TRINITY study. His contributions to this manuscript were invaluable.
Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension
Article first published online: 24 JAN 2012
© 2012 Wiley Periodicals, Inc.
The Journal of Clinical Hypertension
Volume 14, Issue 3, pages 149–157, March 2012
How to Cite
Kereiakes, D. J., Chrysant, S. G., Izzo, J. L., Littlejohn, T., Oparil, S., Melino, M., Lee, J., Fernandez, V. and Heyrman, R. (2012), Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension. The Journal of Clinical Hypertension, 14: 149–157. doi: 10.1111/j.1751-7176.2011.00588.x
- Issue published online: 28 FEB 2012
- Article first published online: 24 JAN 2012
- Manuscript received: September 20, 2011; Revised: November 16, 2011; Accepted: December 2, 2011
Table S1. Titration Effect: Change in Blood Pressure From Week 14 to Week 16.
|JCH_588_sm_ts1-rev.doc||49K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.